Canary: What can this little bird tell you?
ABSTRACT
Dr Gross will provide an update on Canary Medical’s progress toward integrating sensor, power and telemetry technologies with traditional medical implants, with particular attention paid to its first commercial and FDA approved product, the world’s first “smart” knee replacement, canturioTMte. Dr Gross will outline Canary’s digital ecosystem, the technologies that make “smart implants” possible, how these new technologies fit into modern medicine, and he will provide an update on Canary’s pipeline.
BIOGRAPHY
Dr. Jeff Gross is responsible for leading all aspects of product development including R&D, QA, manufacturing, RA, new products, and continual development of the company’s IP portfolio.
Jeff brings over 30 years of experience in cardiovascular, vascular, interventional, spinal, infection protection, and wound healing medical devices. He most recently was a Senior Vice President, R&D, Product Engineering and Chief Technology Officer at Procedural Solution, where he led a multidisciplinary R&D organization of engineers, biologists, chemists, clinical specialists and technicians located in three countries at seven sites conducting medical device, drug, and combination drug/device R&D and product engineering and launched several products that generated about $45 million per year in new product revenue year during this time period with substantive further growth possible. Prior to that, he worked as Senior Vice President, Research and Development, Corporate Officer at Angiotech Pharmaceuticals.
Jeff has over 50 patents & patents pending. Jeff holds a Doctorate of Biomedical Engineering from The University of Memphis, a Master of Science from University of Houston, and a Bachelor of Science from Georgia Institute of Technology.